Impending Consolidation Of The Australian Biotech Sector A Key Topic At Australian Thredbo Biotech Summit July 22 - 23, 2005

There are now 118 listed life science companies in Australia and over the last two years over $500 million has been raised each year through IPOs and follow-on capital raisings. But with the market having entered a downturn in the first quarter of 2005, consolidation is looming within the Australian biotech sector. What are the hurdles for mergers and acquisitions in Australia and how do you find the right deal will be a key topic discussed at the inaugural Thredbo Biotech Summit.

Back to news